161 related articles for article (PubMed ID: 38805128)
1. The Impact of Mitochondria in Ovarian Cancer Cell Metabolism, Proliferation, and Metastasis.
Schatten H
Adv Exp Med Biol; 2024; 1452():119-125. PubMed ID: 38805128
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.
Han Y; Kim B; Cho U; Park IS; Kim SI; Dhanasekaran DN; Tsang BK; Song YS
Oncogene; 2019 Nov; 38(45):7089-7105. PubMed ID: 31409904
[TBL] [Abstract][Full Text] [Related]
3. Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer.
Emmings E; Mullany S; Chang Z; Landen CN; Linder S; Bazzaro M
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626133
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction and cancer metastasis.
Chen EI
J Bioenerg Biomembr; 2012 Dec; 44(6):619-22. PubMed ID: 22892817
[TBL] [Abstract][Full Text] [Related]
6. Costunolide Inhibits the Growth of OAW42-A Multidrug-Resistant Human Ovarian Cancer Cells by Activating Apoptotic and Autophagic Pathways, Production of Reactive Oxygen Species (ROS), Cleaved Caspase-3 and Cleaved Caspase-9.
Fang Y; Li J; Wu Y; Gui J; Shen Y
Med Sci Monit; 2019 May; 25():3231-3237. PubMed ID: 31043579
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide is a positive regulator of the Warburg effect in ovarian cancer cells.
Caneba CA; Yang L; Baddour J; Curtis R; Win J; Hartig S; Marini J; Nagrath D
Cell Death Dis; 2014 Jun; 5(6):e1302. PubMed ID: 24967964
[TBL] [Abstract][Full Text] [Related]
8. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial alterations during carcinogenesis: a review of metabolic transformation and targets for anticancer treatments.
Wang X; Peralta S; Moraes CT
Adv Cancer Res; 2013; 119():127-60. PubMed ID: 23870511
[TBL] [Abstract][Full Text] [Related]
10. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
12. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells.
Kleih M; Böpple K; Dong M; Gaißler A; Heine S; Olayioye MA; Aulitzky WE; Essmann F
Cell Death Dis; 2019 Nov; 10(11):851. PubMed ID: 31699970
[TBL] [Abstract][Full Text] [Related]
13. Role of mitochondria in carcinogenesis.
Tokarz P; Blasiak J
Acta Biochim Pol; 2014; 61(4):671-8. PubMed ID: 25493442
[TBL] [Abstract][Full Text] [Related]
14. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction rather than mtDNA sequence mutation is responsible for the multi-drug resistance of small cell lung cancer.
Ma L; Wang R; Duan H; Nan Y; Wang Q; Jin F
Oncol Rep; 2015 Dec; 34(6):3238-46. PubMed ID: 26502806
[TBL] [Abstract][Full Text] [Related]
16. Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance.
Bhattacharyya S; Saha S; Giri K; Lanza IR; Nair KS; Jennings NB; Rodriguez-Aguayo C; Lopez-Berestein G; Basal E; Weaver AL; Visscher DW; Cliby W; Sood AK; Bhattacharya R; Mukherjee P
PLoS One; 2013; 8(11):e79167. PubMed ID: 24236104
[TBL] [Abstract][Full Text] [Related]
17. Role of mitochondrial alterations in human cancer progression and cancer immunity.
Wang SF; Tseng LM; Lee HC
J Biomed Sci; 2023 Jul; 30(1):61. PubMed ID: 37525297
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism.
Liao J; Qian F; Tchabo N; Mhawech-Fauceglia P; Beck A; Qian Z; Wang X; Huss WJ; Lele SB; Morrison CD; Odunsi K
PLoS One; 2014; 9(1):e84941. PubMed ID: 24409314
[TBL] [Abstract][Full Text] [Related]
19. Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer.
Xue J; Li R; Zhao X; Ma C; Lv X; Liu L; Liu P
Chem Biol Interact; 2018 Mar; 283():59-74. PubMed ID: 29421517
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming of mitochondrial respiration in metastatic cancer.
Herst PM; Grasso C; Berridge MV
Cancer Metastasis Rev; 2018 Dec; 37(4):643-653. PubMed ID: 30448881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
